@januxrx.com
Janux is developing unique T cell immunotherapies designed to generate tumor-specific immune responses to kill tumors without impacting healthy tissue.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Janux Therapeutics is a cutting-edge brand that specializes in the development of unique T cell immunotherapies. Their main goal is to generate immune responses that specifically target tumor cells, leading to the eradication of tumors without harming healthy tissue. With a strong focus on precision and safety, Janux Therapeutics aims to transform the lives of patients by offering tumor-activated immunotherapies.
The brand's platform revolves around bispecific molecules designed to stimulate the immune system within the tumor microenvironment, ensuring that systemic safety issues are minimized. Janux Therapeutics is currently engaged in the development of various programs that selectively modulate T cells to effectively combat cancer. Their clinical trials primarily focus on a lead tumor-activated T cell engager called TRACTr, which specifically addresses prostate cancer.
Janux Therapeutics is at the forefront of innovation in the field of immuno-oncology, constantly striving to deliver breakthrough treatments to patients
Company Type
Public Company
Company Size
51-200
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories